Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 added to the history; prior notices about funding and operating status (v3.4.1) remain in earlier versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedNotice about a lapse in government funding was added, informing users that information may not be up to date and the NIH Clinical Center is open; the page revision history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe history page now shows a glossary toggle, color-coded additions/deletions, and a revision label (v3.4.0). The No FEAR Act data note and the older revision label (v3.3.4) were removed.SummaryDifference0.6%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the history and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe new page footer shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of the previous revision (v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.